Related Experiment Video

Updated: Nov 7, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.6K

Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive

Kai Shen1, Yaxin Fan1, Minjie Yang1

  • 1Institute of Antibiotics, Huashan Hospital, Fudan University, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Key Laboratory of Clinical Pharmacology of Antibiotics, National Health and Family Planning Commission of People's Republic of China, Shanghai, China.

Frontiers in Pharmacology
|May 3, 2021
PubMed

Insights

This study developed a vancomycin population pharmacokinetic model for Chinese children, finding no strong link between drug levels and treatment success. Results suggest a lower target exposure may be effective for pediatric Gram-positive infections.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Pediatrics

Background:

  • Vancomycin is crucial for Gram-positive bacterial infections.
  • Optimizing vancomycin dosing in pediatric populations is challenging.
  • Existing pharmacokinetic/pharmacodynamic (PK/PD) targets may not be universally applicable.

Purpose of the Study:

  • To establish a population pharmacokinetic (PK) model for vancomycin in Chinese pediatric patients.
  • To explore the correlation between PK/PD indices and vancomycin efficacy in this population.
  • To provide evidence for optimizing vancomycin treatment regimens in Chinese children.

Main Methods:

  • A one-compartment population PK model was developed using data from 108 pediatric patients.
  • The model was validated and used to assess correlations between PK/PD indices (Cmin, Cmax, AUC0-24, AUC0-24/MIC) and clinical outcomes.
  • Clinical and microbiological efficacy were evaluated against established PK/PD targets.

Main Results:

  • A validated one-compartment population PK model for vancomycin in Chinese pediatric patients was established.
  • No significant correlation was found between vancomycin PK/PD indices and clinical or microbiological efficacy.
  • Median AUC0-24/MIC values were 200-300, with high clinical effectiveness (>90%).

Conclusions:

  • Chinese pediatric patients with Gram-positive infections may benefit from a lower AUC0-24/MIC target than the current IDSA guideline recommendation (400-600).
  • Current vancomycin dosing strategies may require adjustment for this population.
  • Further prospective studies are needed to confirm optimal dosing regimens.

Keywords:
external validationpediatricpharmacokinetics/pharmacodynamicspopulation pharmacokineticsvancomycin

More Related Videos

Author Spotlight: Standardized Herbal Decoction Protocol for Enhanced Animal Studies03:11

Author Spotlight: Standardized Herbal Decoction Protocol for Enhanced Animal Studies

Published on: June 7, 2024

964
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
50
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
71
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
47
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
98
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
57